Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Tubular HIPK2 is a key contributor to renal fibrosis
Wenzhen Xiao, … , Kyung Lee, John Cijiang He
Wenzhen Xiao, … , Kyung Lee, John Cijiang He
Published July 23, 2020
Citation Information: JCI Insight. 2020;5(17):e136004. https://doi.org/10.1172/jci.insight.136004.
View: Text | PDF
Research Article Nephrology

Tubular HIPK2 is a key contributor to renal fibrosis

  • Text
  • PDF
Abstract

We previously used global Hipk2-null mice in various models of kidney disease to demonstrate the central role of homeodomain-interacting protein kinase 2 (HIPK2) in renal fibrosis development. However, renal tubular epithelial cell–specific (RTEC-specific) HIPK2 function in renal fibrogenesis has yet to be determined. Here, we show that modulation of tubular HIPK2 expression and activity affects renal fibrosis development in vivo. The loss of HIPK2 expression in RTECs resulted in a marked diminution of renal fibrosis in unilateral ureteral obstruction (UUO) mouse models and HIV-associated nephropathy (HIVAN) mouse models, which was associated with the reduction of Smad3 activation and downstream expression of profibrotic markers. Conversely, WT HIPK2 overexpression in RTECs accentuated the extent of renal fibrosis in the setting of UUO, HIVAN, and folic acid–induced nephropathy in mice. Notably, kinase-dead HIPK2 mutant overexpression or administration of BT173, an allosteric inhibitor of HIPK2-Smad3 interaction, markedly attenuated the renal fibrosis in these mouse models of kidney disease, indicating that HIPK2 requires both the kinase activity and its interaction with Smad3 to promote TGF-β–mediated renal fibrosis. Together, these results establish an important RTEC-specific role of HIPK2 in kidney fibrosis and further substantiate the inhibition of HIPK2 as a therapeutic approach against renal fibrosis.

Authors

Wenzhen Xiao, Jing E, Li Bao, Ying Fan, Yuanmeng Jin, Andrew Wang, David Bauman, Zhengzhe Li, Ya-Li Zheng, Ruijie Liu, Kyung Lee, John Cijiang He

×

Figure 1

RTEC-specific ablation of HIPK2 attenuates fibrosis in UUO kidneys.

Options: View larger image (or click on image) Download as PowerPoint
RTEC-specific ablation of HIPK2 attenuates fibrosis in UUO kidneys.
Six-...
Six-week-oldHipk2fl/fl Pax8-rtTA TRE-Cre mice were fed with control chow (Pax8-HIPK2+/+) or doxycycline-supplemented chow (Pax8-HIPK2–/–) for 3 weeks before UUO surgery (n = 5 in each group). Kidneys from UUO or sham surgery were analyzed 14 days after surgery. (A) Representative images of H&E-, Masson’s trichrome (MCT)-, or picrosirius red (PSR)-stained kidneys are shown. Scale bars: 50 μm. (B) Average percentage of PSR-stained area per mouse (n = 5 mice per group). (C) Representative Western blot analysis of Pax8-HIPK2+/+ and Pax8-HIPK2–/– mouse kidney cortices for the expression of HIPK2, phospho-Smad3 (p-Smad3), and total Smad3 (t-Smad3) proteins. (D) Real-time qPCR analysis of fibrosis markers in kidney cortices. Data are presented as mean ± SD. ***P < 0.001 and ****P < 0.0001 when compared between indicated groups by 1-way ANOVA with Tukey’s multiple comparison test. RTEC, renal tubular epithelial cell; UUO, unilateral ureteral obstruction.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts